Induction of protective immunity against Dengue virus type 2: comparison of candidate live attenuated and recombinant vaccines

By Velzing J.   Groen J.   Drouet M.T.   van Amerongen G.   Copra C.   Osterhaus A.D.M.E.   Deubel V.  

Vaccine, Vol. 17, Iss. 11, 1999-03 ,pp. : 1312-1320

Elsevier

Access to resources Recommend Favorite

The use of Toxorhynchites splendens for identification and quantitation of serotypes contained in the tetravalent live attenuated dengue vaccine

By Jirakanjanakit N.   Khin M.M.   Yoksan S.   Bhamarapravati N.  

Vaccine, Vol. 17, Iss. 6, 1999-02 ,pp. : 597-601

Elsevier

Access to resources Recommend Favorite

Safety and immunogenicity of attenuated dengue virus vaccines (Aventis Pasteur) in human volunteers

By Kanesa-thasan N.   Sun W.   Kim-Ahn G.   Van Albert S.   Putnak J.R.   King A.   Raengsakulsrach B.   Christ-Schmidt H.   Gilson K.   Zahradnik J.M.   Vaughn D.W.   Innis B.L.   Saluzzo J.-F.   Hoke Jr C.H.  

Vaccine, Vol. 19, Iss. 23, 2001-04 ,pp. : 3179-3188

Elsevier

Access to resources Recommend Favorite

Immune responses of infants to infection with respiratory viruses and live attenuated respiratory virus candidate vaccines

By Crowe J.E.  

Vaccine, Vol. 16, Iss. 14, 1998-08 ,pp. : 1423-1432

Elsevier

Access to resources Recommend Favorite

Responses of varicella zoster virus (VZV)-specific immunity in seropositive adults after inhalation of inactivated or live attenuated varicella vaccine

By Terada K.   Niizuma T.   Ogita S.   Kataoka N.  

Vaccine, Vol. 20, Iss. 31, 2002-11 ,pp. : 3638-3643

Elsevier

Access to resources Recommend Favorite